Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosilate versus etomidate for anesthesia induction hemodynamics in off-pump CABG
ChiCTR2500097780Phase 4Not yet recruiting
- Sponsor
- Jining First People's Hospital
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and etomidate in coronary arteriosclerosis (2 arms), sponsored by Jining First People's Hospital. Primary endpoint: Change in mean arterial pressure. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
remimazolametomidate
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2500097780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500097780.